Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 58

Sort by

Sort Order Select

Journal Articles

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Cenk Yildirim, MS, Aimaz Afrough, MD, Adanma Anji Ayanambakkam Attanathi, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 1806.

https://doi.org/10.1182/blood-2019-132227

Published: 2019

Journal Articles

Characterizing Inclusion and Exclusion Criteria in Clinical Trials for CAR-T Cellular Therapy Among Adults with Hematologic Malignancies

Jordon Jaggers, Heidi D. Klepin, MD, Tanya M. Wildes, MD, Rebecca L. Olin, MD, Andrew S. Artz, MD, Sarah A Wall, MD, Samantha Jaglowski, MDMPH, Basem M. William, MRCP,MD, Don M. Benson, Jr., MD PhD, Ashley E. Rosko, MD

Blood (2019) 134 (Supplement_1): 5819.

https://doi.org/10.1182/blood-2019-131504

Published: 2019

Journal Articles

Long-Term Experience with Large Granular Lymphocytic Leukemia Evolving after Solid Organ and Hematopoietic Stem Cell Transplantation

Hassan Awada, Reda Z. Mahfouz, MD PhD, Jibran Durrani, Ashwin Kishtagari, MBBS, Deepa Jagadeesh, MDMPH, Alan Lichtin, MD, Brian T. Hill, MD, Betty K. Hamilton, MD, Hetty E. Carraway, MD MBA, Navneet S. Majhail, MD MS, Ronald Sobecks, MD, Valeria Visconte, PhD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD

Blood (2019) 134 (Supplement_1): 1226.

https://doi.org/10.1182/blood-2019-130167

Published: 2019

Journal Articles

CEBPA Gene Mutations Interfere with Expressions of NKG2D Ligands Ulbps in AML Cells and Modulate Their Susceptibility to NK-Mediated Lysis

Meng Liu, Limengmeng Wang, PhD, Huafang Wang, Shan Fu, He Huang, Haowen Xiao

Blood (2019) 134 (Supplement_1): 1257.

https://doi.org/10.1182/blood-2019-129899

Published: 2019

Journal Articles

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

Ayman Qasrawi, MD, Richard L O'Neal, MD, Maxwell M. Krem, MD PhD, Gregory Monohan, MD, Reinhold Munker, MD, Gerhard C. Hildebrandt, MD

Blood (2019) 134 (Supplement_1): 4735.

https://doi.org/10.1182/blood-2019-127687

Published: 2019

Journal Articles

CAR-T Therapy Displays Favorable Gains in Health Outcomes and Competitive Cost-Effectiveness When Compared with Past Innovative Cancer Treatments

James Baumgardner, PhD, Katie Everson, MS, Michelle Brauer, BS, Jie Zhang, PhD, Yanni Hao, PhD, Jamae Liu, PhD, Darius N Lakdawalla, PhD

Blood (2018) 132 (Supplement 1): 322.

https://doi.org/10.1182/blood-2018-99-116763

Published: 2018

Journal Articles

Genome Analysis of a Mantle Cell Lymphoma Case with t(5;18)(p15;q21) Lacking the Translocation Involving Cyclin D1

Kazumi Hagiwara, PhD, Takashi Tokunaga, MD PhD, Hiroatsu Iida, MD PhD, Hirokazu Nagai, MD PhD

Blood (2018) 132 (Supplement 1): 5303.

https://doi.org/10.1182/blood-2018-99-118265

Published: 2018

Journal Articles

Validation of the Khorana Score in Acute Myeloid Leukemia Patients: A Single Institution Experience

Sayeef Mirza, MD MPH, Seongseok Yun, MD PhD, Najla Al Ali, M.Sc, Maher Elharake, MD, Nathan Visweshwar, MD, Daniel Schwartz, Katherine Robinson, MD, Ethan Nowell, BS, Grace Engle, Ibraahim Badat, Thomas Brimer, MD, Amra Kuc, Ashton Sequeira, MD, Sabbir Mirza, Dhiraj Sikaria, Jesus Diaz Vera, Noah Hackney, Rami S. Komrokji, MD, Michael Jaglal, MD

Blood (2018) 132 (Supplement 1): 2278.

https://doi.org/10.1182/blood-2018-99-117545

Published: 2018

Journal Articles

Overcoming a Critical Obstacle Towards Effective and Safe CAR T-Cell Therapeutics

Nandini Mondal, PhD, Mariana Silva, PhD, Ana Castano, MD, Marcela V. Maus, MD PhD, Robert Sackstein, MD PhD

Blood (2018) 132 (Supplement 1): 2056.

https://doi.org/10.1182/blood-2018-99-118675

Published: 2018

Journal Articles

Diagnostic Relevance of 18F-FDG PET/CT in Newly Diagnosed Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) : Single- Center Experience

Viera Sandecka, MD PhD, Ludek Pour, MD, Zdenek Adam, Prof, MD CSc, Martin Stork, MD, Marta Krejci, Prof, MD PhD, Jana Michalcova, MD, Zdenek Kral, MD CSc, Sabina Sevcikova, PhD, Zdeněk Řehák, MD PhD, Renata Koukalova, MD

Blood (2018) 132 (Supplement 1): 1913.

https://doi.org/10.1182/blood-2018-99-111094

Published: 2018

Journal Articles

Role of RasGRP3 in EPO/EPOR Signaling and Transmigration of Human Hematopoietic CD34+ Cells

Yahui Grace Chiu, PhD, Jacquelyn Lillis, MS, Rakesh Singh, PhD, Jane L. Liesveld, MD, Laura M. Calvi, MD, John M Ashton, PhD, Omar S. Aljitawi, MD

Blood (2018) 132 (Supplement 1): 4531.

https://doi.org/10.1182/blood-2018-99-116807

Published: 2018

Journal Articles

Clonal Hematopoiesis: Cell of Origin, Lineage Repartition and Dynamic Evolution during Chemotherapy

Blood (2017) 130 (Supplement 1): 632.

https://doi.org/10.1182/blood.V130.Suppl_1.632.632

Published: 2017

Journal Articles

Between a Rux and a Hard Place: Investigating Causes of Ruxolitinib Discontinuation, Salvage Treatment and Outcome in Myelofibrosis

Savan Shah, MD, Chetasi Talati, MD, Najla Al Ali, M.Sc, Eric Padron, MD, David A Sallman, MD, Kendra L. Sweet, MD, Jeffrey E. Lancet, MD, Alan F. List, MD, Kenneth S. Zuckerman, MD, Rami S. Komrokji, MD, Andrew Kuykendall, MD

Blood (2017) 130 (Supplement 1): 4186.

https://doi.org/10.1182/blood.V130.Suppl_1.4186.4186

Published: 2017

Journal Articles

PPM1D Mutations and up Modulation Phenocopy TP53 Lesions in Myeloid Neoplasms

Reem Elagooz, MS, MD, Mai Aly, MD MS, Cassandra M. Hirsch, BS, Bartlomiej P. Przychodzen, MSc, Teodora Kuzmanovic, BA, Tomas Radivoyevitch, Valeria Visconte, PhD, Sudipto Mukherjee, MD PhD MPH, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD, Jaroslaw P. Maciejewski, PhD MD FACP, Yasunobu Nagata, MD PhD

Blood (2017) 130 (Supplement 1): 4233.

https://doi.org/10.1182/blood.V130.Suppl_1.4233.4233

Published: 2017

Journal Articles

Determination of Red Blood Cell Alloimmunization Rates in Transfused Patients with Hematologic and Oncologic Malignancies

Mariette Asare, MD, Jeanne E Hendrickson, MD, Christopher A Tormey, MD

Blood (2016) 128 (22): 1463.

https://doi.org/10.1182/blood.V128.22.1463.1463

Published: 2016

Journal Articles

Increase of Regulatory γδ T Cells Reduces the Incidence of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Li Gao, Li Xuan, Xiuli Wu, Zhiping Fan, Fen Huang, Zhangshan Yi, Yangqiu Li, Qifa Liu

Blood (2016) 128 (22): 2230.

https://doi.org/10.1182/blood.V128.22.2230.2230

Published: 2016

Journal Articles

Randomized Phase II Multi-Center Trial of Busulfan, Etoposide, and Cyclophosphamide Versus Busulfan, Etoposide, and Melphalan As Conditioning Therapy for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from Consortium for Improving Survival of Lymphoma (CISL)

Kyoung Ha Kim, Lee Jae Hoon, Mark Lee, Kim Hoon-Gu, Young Rok Do, Yong Park, MD PhD, Sung Yong Oh, MD, Ho-Jin Shin, MD PhD, Won Seog Kim, Sung-Kyu Park, MD, Jong-Ho Won, Jee Hyun Kong, Moo-Rim Park, MD, Je-Jung Lee, Jae-Yong Kwak, Hye Jin Kang, MD PhD, Yeung-Chul Mun

Blood (2016) 128 (22): 3466.

https://doi.org/10.1182/blood.V128.22.3466.3466

Published: 2016

Journal Articles

Mutational Analysis of Clonal Hematopoiesis in Solid Tumor Patients Illustrates the Critical Role of Systemic Anti-Cancer Therapies in the Evolution of Somatic Leukemia Disease Alleles

Catherine C. Coombs, MD, Ahmet Zehir, PhD, Sean Devlin, PhD, Ashwin Kishtagari, MD, David M. Hyman, David Solit, MD, Mark Robson, MD, Jose Baselga, MD PhD, Maria Arcila, MD, Martin S. Tallman, MD, Ross L. Levine, MD, Michael Berger, PhD

Blood (2016) 128 (22): 37.

https://doi.org/10.1182/blood.V128.22.37.37

Published: 2016

Journal Articles

Identification of USP14 and UCHL5 As Druggable Oncotargets in Ibrutinib-Resistant Mantle Cell Lymphoma

Aneel Paulus, MDMS, Sharoon Akhtar, MPhil, Kelara Samuel, Hassan Yousaf, Davitte Cogen, Pooja Advani, MBBS, Thomas E. Witzig, MD, George J Weiner, MD, Sikander Ailawadhi, MD, Joachim Gullbo, MD PhD, Stig Linder, PhD, Geraldo Otero-Colon, Kasyapa S. Chitta, PhD, Asher Alban Chanan-Khan, MD

Blood (2015) 126 (23): 1557.

https://doi.org/10.1182/blood.V126.23.1557.1557

Published: 2015

Journal Articles

Clinical Activity of Abemaciclib (LY2835219), a Cell Cycle Inhibitor Selective for CDK4 and CDK6, in Patients with Relapsed or Refractory Mantle Cell Lymphoma

Blood (2014) 124 (21): 3067.

https://doi.org/10.1182/blood.V124.21.3067.3067

Published: 2014

NARROW

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

Characterizing Inclusion and Exclusion Criteria in Clinical Trials for CAR-T Cellular Therapy Among Adults with Hematologic Malignancies

Long-Term Experience with Large Granular Lymphocytic Leukemia Evolving after Solid Organ and Hematopoietic Stem Cell Transplantation

CEBPA Gene Mutations Interfere with Expressions of NKG2D Ligands Ulbps in AML Cells and Modulate Their Susceptibility to NK-Mediated Lysis

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

CAR-T Therapy Displays Favorable Gains in Health Outcomes and Competitive Cost-Effectiveness When Compared with Past Innovative Cancer Treatments

Genome Analysis of a Mantle Cell Lymphoma Case with t(5;18)(p15;q21) Lacking the Translocation Involving Cyclin D1

Validation of the Khorana Score in Acute Myeloid Leukemia Patients: A Single Institution Experience

Overcoming a Critical Obstacle Towards Effective and Safe CAR T-Cell Therapeutics

Diagnostic Relevance of 18F-FDG PET/CT in Newly Diagnosed Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) : Single- Center Experience

Role of RasGRP3 in EPO/EPOR Signaling and Transmigration of Human Hematopoietic CD34+ Cells

Clonal Hematopoiesis: Cell of Origin, Lineage Repartition and Dynamic Evolution during Chemotherapy

Between a Rux and a Hard Place: Investigating Causes of Ruxolitinib Discontinuation, Salvage Treatment and Outcome in Myelofibrosis

PPM1D Mutations and up Modulation Phenocopy TP53 Lesions in Myeloid Neoplasms

Determination of Red Blood Cell Alloimmunization Rates in Transfused Patients with Hematologic and Oncologic Malignancies

Increase of Regulatory γδ T Cells Reduces the Incidence of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Randomized Phase II Multi-Center Trial of Busulfan, Etoposide, and Cyclophosphamide Versus Busulfan, Etoposide, and Melphalan As Conditioning Therapy for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from Consortium for Improving Survival of Lymphoma (CISL)

Mutational Analysis of Clonal Hematopoiesis in Solid Tumor Patients Illustrates the Critical Role of Systemic Anti-Cancer Therapies in the Evolution of Somatic Leukemia Disease Alleles

Identification of USP14 and UCHL5 As Druggable Oncotargets in Ibrutinib-Resistant Mantle Cell Lymphoma

Clinical Activity of Abemaciclib (LY2835219), a Cell Cycle Inhibitor Selective for CDK4 and CDK6, in Patients with Relapsed or Refractory Mantle Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only